vs
太平洋生物科学（ASMB）与纳微半导体（NVTS）财务数据对比。点击上方公司名可切换其他公司
太平洋生物科学的季度营收约是纳微半导体的1.3倍（$10.8M vs $8.6M），太平洋生物科学同比增速更快（57.6% vs -38.7%）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
纳微半导体是全球领先的半导体企业，专注于设计生产氮化镓功率集成电路，其高能效、小体积的功率解决方案广泛应用于消费电子、电动汽车、可再生能源、工业领域，服务覆盖北美、亚洲、欧洲的客户。
ASMB vs NVTS — 直观对比
营收规模更大
ASMB
是对方的1.3倍
$8.6M
营收增速更快
ASMB
高出96.3%
-38.7%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $8.6M |
| 净利润 | $-9.2M | — |
| 毛利率 | — | 98.6% |
| 营业利润率 | -100.9% | -260.6% |
| 净利率 | -85.2% | — |
| 营收同比 | 57.6% | -38.7% |
| 净利润同比 | 4.3% | — |
| 每股收益（稀释后） | $-0.72 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBNVTS
| Q1 26 | — | $8.6M | ||
| Q4 25 | — | $7.3M | ||
| Q3 25 | $10.8M | $10.1M | ||
| Q2 25 | $9.6M | $14.5M | ||
| Q1 25 | $9.4M | $14.0M | ||
| Q4 24 | $7.4M | $18.0M | ||
| Q3 24 | $6.8M | $21.7M | ||
| Q2 24 | $8.5M | $20.5M |
净利润ASMBNVTS
| Q1 26 | — | — | ||
| Q4 25 | — | $-31.8M | ||
| Q3 25 | $-9.2M | $-19.2M | ||
| Q2 25 | $-10.2M | $-49.1M | ||
| Q1 25 | $-8.8M | $-16.8M | ||
| Q4 24 | — | $-39.9M | ||
| Q3 24 | $-9.6M | $-18.7M | ||
| Q2 24 | $-11.2M | $-22.3M |
毛利率ASMBNVTS
| Q1 26 | — | 98.6% | ||
| Q4 25 | — | 38.1% | ||
| Q3 25 | — | 37.9% | ||
| Q2 25 | — | 16.1% | ||
| Q1 25 | — | 37.9% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | — | 39.7% | ||
| Q2 24 | — | 39.0% |
营业利润率ASMBNVTS
| Q1 26 | — | -260.6% | ||
| Q4 25 | — | -567.3% | ||
| Q3 25 | -100.9% | -192.0% | ||
| Q2 25 | -115.2% | -149.4% | ||
| Q1 25 | -105.5% | -180.5% | ||
| Q4 24 | — | -216.9% | ||
| Q3 24 | -160.1% | -133.6% | ||
| Q2 24 | -143.0% | -152.1% |
净利率ASMBNVTS
| Q1 26 | — | — | ||
| Q4 25 | — | -436.1% | ||
| Q3 25 | -85.2% | -190.2% | ||
| Q2 25 | -105.9% | -338.7% | ||
| Q1 25 | -93.6% | -120.1% | ||
| Q4 24 | — | -221.7% | ||
| Q3 24 | -140.4% | -86.4% | ||
| Q2 24 | -130.7% | -109.1% |
每股收益（稀释后）ASMBNVTS
| Q1 26 | — | — | ||
| Q4 25 | — | $-0.14 | ||
| Q3 25 | $-0.72 | $-0.09 | ||
| Q2 25 | $-1.33 | $-0.25 | ||
| Q1 25 | $-1.17 | $-0.09 | ||
| Q4 24 | — | $-0.22 | ||
| Q3 24 | $-1.51 | $-0.10 | ||
| Q2 24 | $-1.98 | $-0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $221.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $420.0M |
| 总资产 | $240.0M | $481.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBNVTS
| Q1 26 | — | $221.0M | ||
| Q4 25 | — | $236.9M | ||
| Q3 25 | $22.5M | $150.6M | ||
| Q2 25 | $24.0M | $161.2M | ||
| Q1 25 | $23.4M | $75.1M | ||
| Q4 24 | $38.3M | $86.7M | ||
| Q3 24 | $28.5M | $98.3M | ||
| Q2 24 | $19.2M | $111.7M |
股东权益ASMBNVTS
| Q1 26 | — | $420.0M | ||
| Q4 25 | — | $443.7M | ||
| Q3 25 | $182.7M | $371.0M | ||
| Q2 25 | $18.1M | $388.9M | ||
| Q1 25 | $27.1M | $341.8M | ||
| Q4 24 | $33.4M | $348.0M | ||
| Q3 24 | $26.0M | $380.8M | ||
| Q2 24 | $34.7M | $388.1M |
总资产ASMBNVTS
| Q1 26 | — | $481.4M | ||
| Q4 25 | — | $500.5M | ||
| Q3 25 | $240.0M | $430.2M | ||
| Q2 25 | $80.8M | $449.4M | ||
| Q1 25 | $99.0M | $370.8M | ||
| Q4 24 | $119.2M | $390.0M | ||
| Q3 24 | $100.3M | $419.4M | ||
| Q2 24 | $115.3M | $439.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | — |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | — |
| 自由现金流率自由现金流/营收 | -140.7% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASMBNVTS
| Q1 26 | — | — | ||
| Q4 25 | — | $-8.1M | ||
| Q3 25 | $-15.1M | $-10.0M | ||
| Q2 25 | $-16.8M | $-11.2M | ||
| Q1 25 | $-23.4M | $-13.5M | ||
| Q4 24 | $-51.1M | $-10.2M | ||
| Q3 24 | $-15.2M | $-13.7M | ||
| Q2 24 | $-17.1M | $-15.1M |
自由现金流ASMBNVTS
| Q1 26 | — | — | ||
| Q4 25 | — | $-8.2M | ||
| Q3 25 | $-15.2M | $-10.7M | ||
| Q2 25 | — | $-11.9M | ||
| Q1 25 | — | $-13.6M | ||
| Q4 24 | $-51.1M | $-10.8M | ||
| Q3 24 | — | $-14.3M | ||
| Q2 24 | $-17.1M | $-17.9M |
自由现金流率ASMBNVTS
| Q1 26 | — | — | ||
| Q4 25 | — | -111.8% | ||
| Q3 25 | -140.7% | -106.1% | ||
| Q2 25 | — | -82.2% | ||
| Q1 25 | — | -96.8% | ||
| Q4 24 | -695.2% | -59.8% | ||
| Q3 24 | — | -65.9% | ||
| Q2 24 | -200.6% | -87.3% |
资本支出强度ASMBNVTS
| Q1 26 | — | — | ||
| Q4 25 | — | 0.7% | ||
| Q3 25 | 0.4% | 7.0% | ||
| Q2 25 | 0.0% | 4.7% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | 0.4% | 3.1% | ||
| Q3 24 | 0.0% | 2.6% | ||
| Q2 24 | 0.2% | 13.4% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
